HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler-Najjar Syndrome Type I.

Abstract
Adeno-associated virus (AAV) -mediated gene therapy is a promising strategy to treat liver-based monogenic diseases. However, two major obstacles limit its success: first, vector dilution in actively dividing cells, such as hepatocytes in neonates/children, due to the non-integrating nature of the vector; second, development of an immune response against the transgene and/or viral vector. Crigler-Najjar Syndrome Type I is a rare monogenic disease with neonatal onset, caused by mutations in the liver-specific UGT1 gene, with toxic accumulation of unconjugated bilirubin in plasma, tissues and brain. To establish an effective and long lasting cure, we applied AAV-mediated liver gene therapy to a relevant mouse model of the disease. Repeated gene transfer to adults by AAV-serotype switching, upon neonatal administration, resulted in lifelong correction of total bilirubin (TB) levels in both genders. In contrast, vector loss over time was observed after a single neonatal administration. Adult administration resulted in lifelong TB levels correction in male, but not female Ugt1-/- mice. Our findings demonstrate that neonatal AAV-mediated gene transfer to the liver supports a second transfer of the therapeutic vector, by preventing the induction of an immune response and supporting the possibility to improve AAV-therapeutic efficacy by repeated administration.
AuthorsL Bočkor, G Bortolussi, A Iaconcig, G Chiaruttini, C Tiribelli, M Giacca, F Benvenuti, L Zentilin, A F Muro
JournalGene therapy (Gene Ther) Vol. 24 Issue 10 Pg. 649-660 (10 2017) ISSN: 1476-5462 [Electronic] England
PMID28805798 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • UGT1A1 enzyme
  • Glucuronosyltransferase
  • Bilirubin
Topics
  • Animals
  • Bilirubin (metabolism)
  • Brain (metabolism)
  • Crigler-Najjar Syndrome (therapy)
  • Dependovirus (genetics)
  • Female
  • Gene Transfer Techniques
  • Genetic Therapy (methods)
  • Genetic Vectors (genetics)
  • Glucuronosyltransferase (genetics, metabolism)
  • HEK293 Cells
  • Humans
  • Liver (metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Serogroup

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: